The burden of liver diseases is substantial, demanding groundbreaking therapeutic strategies. Cellular therapies represent a particularly promising avenue, offering the chance to restore damaged hepatic tissue and improve clinical outcomes. Currently, research focuses on several methods, including the delivery of adult cellular entities directly in